We're #hiring a new Associate Scientist - In Vivo Pharmacology/Biology in Seattle, Washington. Apply today or share this post with your network.
AltPep
Biotechnology
Seattle, Washington 1,288 followers
AltPep develops early disease-modifying treatments and detection tools for amyloid diseases.
About us
AltPep develops early disease-modifying treatments and detection tools for amyloid diseases by targeting one of the earliest molecular triggers – toxic soluble oligomers. These oligomers are associated with many diseases, including neurodegenerative diseases and type 2 diabetes. Decades of scientific research by the Daggett Research Group culminated in the discovery of a novel protein structure, alpha-sheet, the foundation of our innovative approach. Our lead program aims to identify Alzheimer’s Disease long before symptoms occur and then neutralize the toxic soluble oligomers associated with the disease.
- Website
-
http://www.altpep.com
External link for AltPep
- Industry
- Biotechnology
- Company size
- 11-50 employees
- Headquarters
- Seattle, Washington
- Type
- Privately Held
- Founded
- 2019
- Specialties
- Biotechnology, Amyloid Disease, and Alzheimer's Disease
Locations
-
Primary
Get directions
100 NE Northlake Way
Suite 300
Seattle, Washington 98105, US
Employees at AltPep
-
Patrik Edenholm
-
Chandresh Gajera
In-vivo biology and translational research using neurodegenerative disease models
-
Nancy Hill
Biotechnology executive of high-growth, innovation-driven companies.
-
Albert Choi, MBA
Business Operations Manager @ AltPep | Ex-Consultant @Accenture | Corporate Strategy and Operational Excellence
Updates
-
We're #hiring a new Scientist, In Vivo Pharmacology/Biology in Seattle, Washington. Apply today or share this post with your network.
-
We're #hiring a new Medical Laboratory Scientist in Seattle, Washington. Apply today or share this post with your network.
-
We're #hiring a new Scientist - Protein Biophysicist in Seattle, Washington. Apply today or share this post with your network.
-
UW published an interesting overview of the work led by Valerie Daggett identifying a link between bacterial infections and Alzheimer’s disease. Check out the article here https://lnkd.in/gK2P6XmZ #Innovation #AlzheimerDisease #UW #Research
-
We are excited about the GeekWire Awards tomorrow! AltPep's Valerie Daggett has been nominated for Startup CEO of the year, along with some other great start-up CEOs. Last year AltPep won GeekWire’s Health Innovation of the Year award. Hope to see you at the event! Get your GeekWire Awards tickets: https://lnkd.in/e5awbXau #geekwireawards #innovation #AlzheimersDisease
Get your GeekWire Awards tickets: May 9 event celebrates the best in tech and innovation
geekwire.com
-
AltPep CEO, Valerie Daggett presented at the 12th Annual Alzheimer’s and Parkinson’s Drug Development Summit today. Her talk, titled “Diagnostics and Therapeutics for Selective Targeting of Early Toxic Oligomers” overviewed AltPep’s SOBA assay and SOBIN therapeutic in Alzheimer’s disease, as well as the application of AltPep’s platform to other amyloid diseases including Parkinson’s disease. Click below to read her bio and learn more about the Summit. #innovation #AlzheimersDisease #ParkinsonsDisease #Research
Valerie Daggett - Alzheimer’s & Parkinson’s Drug Development Summit
alzheimers-parkinsons-summit.com
-
AltPep CEO Valerie Daggett will be presenting at Life Science Innovation Northwest 2024 on April 18th! Her presentation will be part of the Central Nervous System and Autoimmune Diseases portion of the company presentations. Follow the link to see the full schedule. #Innovation #AlzheimersDisease #Research #Seattle
Life Science Innovation Northwest 2024 | Life Science Washington
lifesciencewa.org
-
We are so proud of the amazing work and leadership of our CEO Valerie Daggett. Valerie has been nominated for GeekWire’s Startup CEO of the Year and voting ends this Friday (4/12). So, if you haven't voted already, we would appreciate your support. Just follow the link and fill out the ballot today! https://lnkd.in/dWTJNq7Z #GeekwireAwards #Seattle #Innovation #AlzheimersDisease
-
-
We all had a great time at the official Grand Opening of Alexandria’s 1150 Eastlake building. We are so excited to be part of this new facility! Our new labs are amazing, and we can hardly get over the view! #AlzheimersDisease #Research #Innovation #Seattle
-